Clinical Trials Browser

Chordoma, Myoepithelioma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Nerve Sheath Neoplasms, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

NCT04091295 2026-03-04

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Available

BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Chordoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Neurofibrosarcoma

NCT05041127 2026-02-19

Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma

Phase 2 Active not recruiting

29 enrolled

Sarcoma

Chordoma

NCT05861245 2026-01-23

Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base

Phase NA Recruiting

20 enrolled

Sarcoma

Chondrosarcoma, Chordoma

NCT02989636 2026-01-06

Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma

Phase 1 Active not recruiting

21 enrolled

Sarcoma

Chordoma

NCT01407198 2025-12-19

Nilotinib With Radiation for High Risk Chordoma

Phase 1 Completed

23 enrolled

Sarcoma

Chordoma

NCT04416568 2025-12-17

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

Phase 2 Active not recruiting

45 enrolled

Sarcoma

Chordoma, Sarcoma, Rhabdoid Tumor

NCT00496119 2025-12-16

Proton Beam Therapy for Chordoma Patients

Phase 2 Active not recruiting

19 enrolled

Sarcoma

Chordoma

NCT01449149 2025-12-05

Proton Radiation for Chordomas and Chondrosarcomas

Phase NA Completed

54 enrolled 11 charts

Sarcoma

Chondrosarcoma, Chordoma

NCT06535997 2025-08-06

PRIMHADRON

Completed

62 enrolled

LymphoidSarcoma

Chondrosarcoma, Chordoma, Carcinoma, Adenoid Cystic, Hemangiosarcoma, Lymphoma, Follicular, Neoplasms, Sarcoma, Osteosarcoma

NCT04087902 2025-07-03

Long-Term Longitudinal QoL in Patients Undergoing EEA

Recruiting

400 enrolled

CNSEndocrineSarcoma

Chondrosarcoma, Chordoma, Craniopharyngioma, Encephalocele, Meningioma, Pituitary Neoplasms, Esthesioneuroblastoma, Olfactory, Central Nervous System Cysts

Clinical Trials

Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors

A Study of ERAS-601 in People With Chordoma

PALANGI3

Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma

Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base

Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma

Nilotinib With Radiation for High Risk Chordoma

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

Proton Beam Therapy for Chordoma Patients

Proton Radiation for Chordomas and Chondrosarcomas

PRIMHADRON

Long-Term Longitudinal QoL in Patients Undergoing EEA